Literature DB >> 18292313

AIDS research. Microbicide fails to protect against HIV.

Jon Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18292313     DOI： 10.1126/science.319.5866.1026b

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  19 in total

1.  Highly potent, fully recombinant anti-HIV chemokines: reengineering a low-cost microbicide.

Authors:  Hubert Gaertner; Fabrice Cerini; Jean-Michel Escola; Gabriel Kuenzi; Astrid Melotti; Robin Offord; Irène Rossitto-Borlat; Rebecca Nedellec; Janelle Salkowitz; Guy Gorochov; Donald Mosier; Oliver Hartley
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-12       Impact factor: 11.205

Review 2.  Adherence to biomedical HIV prevention methods: considerations drawn from HIV treatment adherence research.

Authors:  Michael J Stirratt; Christopher M Gordon
Journal:  Curr HIV/AIDS Rep       Date:  2008-11       Impact factor: 5.071

3.  An aptamer that neutralizes R5 strains of HIV-1 binds to core residues of gp120 in the CCR5 binding site.

Authors:  Carla Cohen; Mario Forzan; Brian Sproat; Ralph Pantophlet; Ian McGowan; Dennis Burton; William James
Journal:  Virology       Date:  2008-09-17       Impact factor: 3.616

Review 4.  Emerging nanotechnology approaches for HIV/AIDS treatment and prevention.

Authors:  Tewodros Mamo; E Ashley Moseman; Nagesh Kolishetti; Carolina Salvador-Morales; Jinjun Shi; Daniel R Kuritzkes; Robert Langer; Ulrich von Andrian; Omid C Farokhzad
Journal:  Nanomedicine (Lond)       Date:  2010-02       Impact factor: 5.307

5.  Preclinical evaluation of the immunomodulatory lymphocyte trafficking drug FTY720 for HIV prevention in the female genital mucosa of macaques.

Authors:  Monica Morris; Rachael D Aubert; Katherine Butler; Tara Henning; James Mitchell; Leecresia Jenkins; David Garber; Janet McNicholl; Ellen N Kersh
Journal:  J Med Primatol       Date:  2014-10       Impact factor: 0.667

6.  Glycerol monolaurate prevents mucosal SIV transmission.

Authors:  Qingsheng Li; Jacob D Estes; Patrick M Schlievert; Lijie Duan; Amanda J Brosnahan; Peter J Southern; Cavan S Reilly; Marnie L Peterson; Nancy Schultz-Darken; Kevin G Brunner; Karla R Nephew; Stefan Pambuccian; Jeffrey D Lifson; John V Carlis; Ashley T Haase
Journal:  Nature       Date:  2009-03-04       Impact factor: 49.962

7.  A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.

Authors:  Vanessa Pirrone; Shendra Passic; Brian Wigdahl; Robert F Rando; Mohamed Labib; Fred C Krebs
Journal:  J Biomed Biotechnol       Date:  2010-05-31

Review 8.  Pre-exposure prophylaxis state of the science: empirical analogies for research and implementation.

Authors:  Sarit A Golub; Don Operario; Pamina M Gorbach
Journal:  Curr HIV/AIDS Rep       Date:  2010-11       Impact factor: 5.071

9.  Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course.

Authors:  Nicole Prada; Brandi Davis; Patrick Jean-Pierre; Matthew La Roche; Fuh-Mei Duh; Mary Carrington; Michael Poles; Saurabh Mehandru; Hiroshi Mohri; Martin Markowitz
Journal:  J Acquir Immune Defic Syndr       Date:  2008-10-01       Impact factor: 3.731

10.  Increased CCL2 expression and macrophage/monocyte migration during microbicide-induced vaginal irritation.

Authors:  Carsten Alt; Travis Harrison; Linda Dousman; Nahoko Fujita; Ken Shew; Thanh-Thuy Tran; Sara Shayesteh; Akihiro Matsukawa; Jon Mirsalis; Annalisa D'Andrea
Journal:  Curr HIV Res       Date:  2009-11       Impact factor: 1.581
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.